This critical review highlights the progress in (195)Pt NMR over the last 25 years. In particular, some of the recent applications of (195)Pt NMR in catalytic and mechanistic studies, intermetallics and drug binding studies are discussed. (195)Pt NMR chemical shifts obtained from both theoretical studies and experiments are presented for Pt(0), Pt(II), Pt(III) and Pt(IV) complexes. (195)Pt coupling with various nuclei (viz. coupling constants) have also been collected in addition to data on (195)Pt relaxation. The latest developments in the theoretical knowledge and experimental advances have made (195)Pt NMR into a rich source of information in many fields. (164 references.).
The first example of the use of (195)Pt PGSE diffusion data (D values) to recognize the solvent dependence of aggregation of the hexachloroplatinate dianion in Na(2)PtCl(6) (1) and in H(2)PtCl(6) (2) is reported. In water, the ions are separated; however, in methanol the D values suggest ion pairing and/or aggregation. Additional (1)H and (31)P diffusion data for organometallic Pt complexes trans-PtX(Aryl)(L)(2) (where L = PEt(3) or PPh(3)) and Pt(C(7)H(4)O(2))(L(1))(L(2)) (where L(1) and L(2) = a variety of ligand types) reveal that phenyl phosphines afford relatively large hydrodynamic radii r(h). The presence of a substituent on the aryl ligand of PtX(Aryl)(L)(2) does not markedly affect the D values, whereas a substituent of similar size added to a PPh(3) group in Pt(C(7)H(4)O(2))(L(1))(L(2)) markedly changes both D and r(h) values. There is only a small concentration dependence of the D values in PtX(Aryl)(L)(2) on changing from 2 to 10 mM.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.